NEOSTOMOSAN, Koncentrát pro kožní roztok
NEOSTOMOSAN, Koncentrát pro kožní roztok
Authorised
- Tetramethrin
- Cypermethrin
Product identification
Medicine name:
NEOSTOMOSAN, Koncentrát pro kožní roztok
Active substance:
- Tetramethrin
- Cypermethrin
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Tetramethrin5.00milligram(s)1.00millilitre(s)
-
Cypermethrin50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Concentrate for cutaneous solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC30
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Animal Health Slovakia s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
- Chemark Kft.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/444/92–C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: